Avenue Therapeutics Inc. (ATXI)
NASDAQ: ATXI
· Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM
0.55
9.26%
After-hours: Aug 15, 2025, 03:17 PM EDT
Avenue Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.21M | -11.69M | -9.49M | -5.89M | -7.2M | -10.46M | -10.58M | -11.76M | -8.34M | -3.6M | -5.04M | -5.25M | -5.59M | -3.73M | -3.81M | -3.97M | -4.91M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.23M | 1.24M | 1.02M | 1.25M | 1.09M | 906K | 611K | 75K | 91K | 649K | 780K | 824K | 897K | 442K | 417K | 509K | 609K |
Other Working Capital | -276K | -325K | 59K | n/a | -1.93M | 1.04M | 814K | 1.1M | 2.65M | -206K | -783.59K | -427.59K | 29.41K | 7.41K | 539K | 135K | 54K |
Other Non-Cash Items | 557K | 1.05M | -1.78M | -3.35M | -1.29M | 398K | -2.29M | -683K | -2.4M | -4.39M | 1.16M | 892K | 495K | 835K | 105K | 184K | 471K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -340K | n/a | -538K | -800K | -3.79M | -290K | 966K | 1.44M | 3.88M | 408K | -370K | -187K | 324K | -461K | -346K | -677K | -451K |
Operating Cash Flow | -7.09M | -9.03M | -10.59M | -8.59M | -11M | -9.45M | -11.3M | -10.96M | -7.24M | -7.6M | -4.63M | -4.61M | -4.37M | -3.75M | -3.74M | -4.14M | -4.75M |
Capital Expenditures | n/a | n/a | 3M | 2M | n/a | n/a | -3M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 1M | 1M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -3M | -3M | -3M | -3M | -3K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -2K | -2K |
Investing Cash Flow | n/a | n/a | 3M | 2M | n/a | n/a | -3M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | 999K | 998K | 998K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -1.1M | -1.1M | -1.1M | -1.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 12.06M | 14.55M | 8.85M | 8.21M | 4.53M | 1K | 10.59M | 10.54M | 10.54M | 10.54M | -119K | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 7.4M | 9.84M | 13.02M | 12.93M | 8.96M | 7.53M | 14.24M | 13.64M | 13.64M | 10.54M | -114.62K | 4.38K | 4.38K | 4.38K | n/a | n/a | n/a |
Net Cash Flow | 308K | 811K | 2.44M | 3.35M | -5.04M | -4.92M | -56K | 681K | 6.4M | 2.94M | -368K | -231K | 8K | 631K | -3.74M | -4.14M | -4.75M |
Free Cash Flow | -7.09M | -9.03M | -7.59M | -6.59M | -11M | -9.45M | -14.3M | -12.96M | -7.24M | -7.6M | -4.63M | -4.61M | -4.37M | -3.75M | -2.74M | -3.14M | -3.75M |